If you are looking for an answer to the question What is Artificial Intelligence? and you only have a minute, then here's the definition the Association for the Advancement of Artificial Intelligence offers on its home page: "the scientific understanding of the mechanisms underlying thought and intelligent behavior and their embodiment in machines."
However, if you are fortunate enough to have more than a minute, then please get ready to embark upon an exciting journey exploring AI (but beware, it could last a lifetime) …
New software developed by Peter Mac and collaborators is helping patients diagnosed with acute lymphoblastic leukemia (ALL) to determine what subtype they have. ALL is the most common childhood cancer in the world, and also affects adults. "Thirty to forty percent of all childhood cancers are ALL, it's a major pediatric cancer problem," says Associate Professor Paul Ekert from Peter Mac and the Children's Cancer Institute, who was involved in this work. More than 300 people are diagnosed with the disease in Australia each year, and more than half of those are young children under the age of 15. Determining what subtype of ALL a patient has provides valuable information about their prognosis, and how they should best be treated.
C3.ai (NYSE:AI) is a leading software company, which provides Artificial Intelligence services to enterprises. The company is poised to ride the wave of growth forecasted for AI. The global Artificial Intelligence (AI) market is forecasted to grow at a meteoric 20.1% CAGR from $387 billion in 2022 to over $1.3 trillion by 2029. C3.ai serves an envious list of large reputable customers from The US Air Force and the Department of Defence, to large energy companies such as Shell & Engie. They have been growing revenues at a 40% CAGR over the past couple of years, while the stock price has declined massively.
In an ideal deployment, all workloads would be centralized in the cloud to enjoy the benefits of scale and simplicity. These deployments can take on the form of edge AI and/or cloud AI, each offering their own potential unique use cases, benefits, and challenges. With this in mind, it will take careful consideration when choosing the best model for your business. Edge AI and cloud AI play a complementary role in ensuring the models serving AI deployments are continuously improving without compromising on data quality and quantity. Cloud AI complements the instant decision-making of edge AI by providing deeper insights for more longitudinal data.
This talk explores digital transformation accelerators arising from two shocks – the pandemic and the future of artificial intelligence (AI). Presented by Jim Spohrer, retired IBM Executive, and member of the Board of Directors of the non-profit International Society of Service Innovation Professionals (ISSIP). In 2011 during IBM's Centennial Celebration, Jim Spohrer was recognized as an IBM Innovation Champion for his contributions to service science. Service science is one of the 100 innovations celebrated during IBM's Centennial as an IBM Icon of Progress. Will we get a copy of the deck?
Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com. In the coming weeks, students around the nation will hear their names read aloud, walk across a platform and move their tassels to signify graduation from high school or college. After years of working toward receiving their diploma or degree, they are now off to start a new adventure in their lives. And, for others, there may be the apprehension of not knowing what is next. As a college president, here are five pieces of advice I have for graduating seniors.
The latest breakthrough is the transformer model. Before this, to take account of temporal correlations, we needed to use recurrent neural networks, which were much more difficult to train and much less successful. When they worked they worked wonders, but most of the time it was better to avoid such an architecture. Then the idea of attention was invented and a number of different language models making use of it started to change the way we think about neural networks. So much so that they were renamed "foundational models" and are taken by one faction to be the future of AI and by the remaining faction as being nothing but a magic trick with no substance.
As the metaverse industry is expected to be an $800 billion market by 2024, we continue to learn new ways this immersive, virtual environment might better enable us to connect with each other from anywhere in the world. This comes at a time when many are already participating in and benefitting from virtual activities that otherwise would not be possible due to constraints of distance, time or cost. In enabling new opportunities for virtual rather than in-person instruction, the metaverse has the power to transform access to education and the way we learn. The types of education that the metaverse can accommodate are varied, from school-based interactive learning and workplace training to professional accreditation. In so many ways, the metaverse is offering new chances for people to learn what they want by mitigating obstacles of accessibility.
Author summary Interest in machine learning as applied to challenges in medicine has seen an exponential rise over the past decade. A key issue in developing machine learning models is the availability of sufficient high-quality data. Another related issue is a requirement to validate a locally trained model on data from external sources. However, sharing sensitive biomedical and clinical data across different hospitals and research teams can be challenging due to concerns with data privacy and data stewardship. These issues have led to innovative new approaches for collaboratively training machine learning models without sharing raw data. One such method, termed ‘federated learning,’ enables investigators from different institutions to combine efforts by training a model locally on their own data, and sharing the parameters of the model with others to generate a central model. Here, we systematically review reports of successful deployments of federated learning applied to research problems involving biomedical data. We found that federated learning links research teams around the world and has been applied to modelling in such as oncology and radiology. Based on the trends we observed in the studies reviewed in our paper, we observe there are opportunities to expand and improve this innovative approach so global teams can continue to produce and validate high quality machine learning models.